Human Genome Epidemiology Literature Finder
Records 1 - 21 (of 21 Records) |
Query Trace: Thoracic Neoplasms and ALK[original query] |
---|
Clonally-related primary ALK rearranged adenocarcinoma and associated metastatic lesions. Thoracic cancer 2018 May . Zhu You-Cai, Deng Yun-Te, Wang Wen-Xian, Xu Chun-Wei, Zhuang Wu, Du Kai- |
Clinicopathological features of younger (aged ? 50 years) lung adenocarcinoma patients harboring the EML4-ALK fusion gene. Thoracic cancer 2018 Mar . Kometani Takuro, Sugio Kenji, Osoegawa Atsushi, Seto Takashi, Ichinose Yuki |
Prognostic role of circulating tumor cells in patients with EGFR-mutated or ALK-rearranged non-small cell lung cancer. Thoracic cancer 2018 3 9 (5): 640-645. Tong Bing, Xu Yan, Zhao Jing, Chen Minjiang, Zhong Wei, Xing Jia, Wang Mengzh |
Expression and copy number gains of the RET gene in 631 early and mid stage non-small cell lung cancer cases. Thoracic cancer 2018 Feb . Tan Ling, Hu Yerong, Tao Yongguang, Wang Bin, Xiao Jun, Tang Zhenjie, Lu Ting, Tang H |
PD-L1 expression in ROS1-rearranged non-small cell lung cancer: A study using simultaneous genotypic screening of EGFR, ALK, and ROS1. Thoracic cancer 2019 01 10 (1): 103-110. Lee Jongmin, Park Chan Kwon, Yoon Hyoung-Kyu, Sa Young Jo, Woo In Sook, Kim Hyo Rim, Kim Sue Youn, Kim Tae-Ju |
The prognostic implications of EGFR mutation and ALK rearrangement for the long-term outcomes of patients with resected lung adenocarcinomas. Thoracic cancer 2019 Jun . Kim Hyungjin, Lee Hyun-Ju, Hong Hyunsook, Kim Young Jae, Kim Kwang Gi, Jeon Yoon Kyung, Kim Young T |
Real-world data on EGFR/ALK gene status and first-line targeted therapy rate in newly diagnosed advanced non-small cell lung cancer patients in Northern China: A prospective observational study. Thoracic cancer 2019 5 10 (7): 1521-1532. Liang Hongge, Song Xia, Zhang Yuhui, Zhang Shucai, Li Fang, Fang Jian, Li Junling, Liang Li, Nie Ligong, Ma Kewei, Zhang Liangming, Wang Xiaohong, Xu Junjun, Wei Yanxia, Wang Jinghui, Song Qi, Tian Guangming, Mu Yuxin, Gu Yangchun, Yang Lei, Sun Ping, Zhong Wei, Zhao Jing, Xu Yan, Chen Minjiang, Wang Mengzh |
Clinical and computed tomography characteristics of non-small cell lung cancer with ALK gene rearrangement: Comparison with EGFR mutation and ALK/EGFR-negative lung cancer. Thoracic cancer 2019 2 10 (4): 872-879. Mori Mio, Hayashi Hideyuki, Fukuda Minoru, Honda Sumihisa, Kitazaki Takeshi, Shigematsu Kazuto, Matsuyama Naohiro, Otsubo Mayumi, Nagayasu Takeshi, Hashisako Mikiko, Tabata Kazuhiro, Uetani Masataka, Ashizawa Kazu |
Tyrosine kinase inhibitor acquired resistance mechanism alternates between EGFR and ALK in a lung adenocarcinoma patient. Thoracic cancer 2019 2 10 (5): 1252-1255. Hu Yijuan, Xiao Lili, Yang Nong, Zhang Yongcha |
Lung cancer family history and exposure to occupational/domestic coal combustion contribute to variations in clinicopathologic features and gene fusion patterns in non-small cell lung cancer. Thoracic cancer 2019 (4): 695-707. Chen Ying, Li Guangjian, Lei Yujie, Yang Kaiyun, Niu Huatao, Zhao Jie, He Rui, Ning Huanqi, Huang Qiubo, Zhou Qinghua, Huang Yunch |
Low frequency of mutation of epidermal growth factor receptor (EGFR) and arrangement of anaplastic lymphoma kinase (ALK) in primary pulmonary lymphoepithelioma-like carcinoma. Thoracic cancer 2019 12 11 (2): 346-352. Yin Kai, Feng Hui-Bo, Li Lin-Lin, Chen Yu, Xie Zhi, Lv Zhi-Yi, Guo Wei-Bang, Lu Dan-Xia, Yang Xue-Ning, Yan Wen-Qing, Wu Yi-Long, Zhang Xu-Ch |
Status of 10 targeted genes of non-small cell lung cancer in eastern China: A study of 884 patients based on NGS in a single institution. Thoracic cancer 2020 Jul . Li Dan, Ding Li, Ran Wenwen, Huang Yan, Li Guangqi, Wang Chengqin, Xiao Yujing, Wang Xiaonan, Lin Dongliang, Xing Xiaomi |
Pathologic complete response to preoperative immunotherapy in a lung adenocarcinoma patient with bone metastasis: A case report. Thoracic cancer 2020 2 11 (4): 1094-1098. Tang Yong, Li Yadan, Zhang Lei, Tong Guihui, Ou Zhu'an, Wang Zhuocai, Zhang Henghui, Qiao Guib |
Response rate of patients with baseline brain metastases from recently diagnosed non-small cell lung cancer receiving radiotherapy according to EGFR, ALK and KRAS mutation status. Thoracic cancer 2020 Feb . Arrieta Oscar, Ramírez-Tirado Laura-Alejandra, Caballé-Perez Enrique, Mejia-Perez Alberto, Zatarain-Barrón Zyanya Lucia, Cardona Andrés F, Lozano-Ruíz Francisco, Segura-González Manuel, Cruz-Rico Graciela, Maldonado Federico, Rosell Rafa |
Comprehensive genomic profiling of Brazilian non-small cell lung cancer patients (GBOT 0118/LACOG0418). Thoracic cancer 2020 Dec . Mascarenhas Eldsamira, Gelatti Ana Caroline, Araújo Luiz Henrique, Baldotto Clarissa, Mathias Clarissa, Zukin Mauro, Werutsky Gustavo, Pacheco Patricia, Gomes Rafaela, de Castro Gilberto, Cordeiro de Lima Vladmir Cláud |
Genomic characteristics of driver genes in Chinese patients with non-small cell lung cancer. Thoracic cancer 2020 12 12 (3): 357-363. Si Xiaoyan, Pan Ruili, Ma Shaohua, Li Lin, Liang Li, Zhang Ping, Chu Yuping, Wang Hanping, Wang Mengzhao, Zhang Xiaotong, Zhang |
Primary resistance to alectinib in a patient with STRN-ALK-positive non-small cell lung cancer: A case report. Thoracic cancer 2021 5 12 (12): 1927-1930. Sun Kunyan, Nie Ligong, Nong Lin, Cheng Yu |
Clinicopathological and prognostic implications of ALK rearrangement in patients with completely surgically resected lung adenocarcinoma. Thoracic cancer 2021 Oct . Zhang Huan, Shan Guangyao, Cai Benjie, Bi Guoshu, Chen Zhencong, Liang Jiaqi, Besskaya Valeria, Zheng Yuansheng, Guo Weigang, Wang Lin, Xu Songtao, Zhan Che |
Genotyping of cerebrospinal fluid in lung cancer patients with leptomeningeal metastasis. Thoracic cancer 2022 Sep 13 (18): 2574-2583. Nie Naifu, Zhou Haodong, Zhang Kejun, Liu Lan, Luo Nuo, Wang Renyuan, Li Xin, Zhu Mengxiao, Hu Chen, Wang Yubo, Liu Zhulin, Li Li, He Yo |
ERBB2 exon 20 insertions are rare in Brazilian non-small cell lung cancer. Thoracic cancer 2022 Oct . de Oliveira Cavagna Rodrigo, Zaniolo Beatriz Garbe, de Paula Flávia Escremim, Berardinelli Gustavo Noriz, Santana Iara, da Silva Eduardo Caetano Albino, Dias Josiane Mourão, Jacinto Alexandre Arthur, da Nóbrega Oliveira Rachid Eduardo Noleto, de Marchi Pedro, Leal Letícia Ferro, Reis Rui Manu |
Dynamic monitoring of circulating tumor DNA to analyze genetic characteristics and resistance profile of lorlatinib in ALK positive previously treated NSCLC. Thoracic cancer 2023 6 . Xiya Ma, Kun Zhang, Jing Xu, Hongjun Gao, Shaoxing Yang, Haifeng Qin, Hong Wang, Fang Gao, Xiaoqing L |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source: